PEGINTRON(TM) And REBETOL(R) Approved In European Union For Retreating Hepatitis C Patients Who Failed Previous Pegylated Or Non-Pegylated Interferon
November 16th, 2007 by admin
Schering-Plough Corporation (NYSE: SGP) announced that the European Commission on October 30 approved 48-week standard-dose PEGINTRON(TM) (peginterferon alfa- 2b, 1. [click link for full article]
Posted in Liver treatment |